Clinical review for general practice

ISSN (Print) 2713-2552
ISSN (Online) 2782-5671
  • Home
  • about
  • archives
  • contacts
left
FULLSCREEN > Archive > 2020 > Vol 1, №3 (2020) > Postmenopausal women – comorbid patients

Postmenopausal women – comorbid patients

Tatyana Yu. Pestrikova , Elena A. Yurasova , Olga G. Sherbakova , Marina А. Shveeva

For citation:


  • Abstract
  • About the Author
  • References

Abstract

Relevance. As the prevention and treatment of diseases improves, the average life expectancy of the population increases. For many of our contemporaries, a third of their lives are postmenopausal. Menopause-related health problems are increasingly common and require the attention of healthcare professionals.
Aim. To raise awareness of gynecologists, urologists and other specialists about the medico-social significance of the problems of women in the menopausal period based on the analysis of literature sources and analysis of clinical cases.
Materials and methods. To write this review, a search was carried out for domestic and foreign publications in Russian and international search systems (PubMed, eLibrary, etc.) over the past 20 years. The review included articles from the peer-reviewed literature. An analysis of 2 clinical cases with comorbid pathology in menopausal patients is presented.
Results. The review presents data on age-related physiological changes and quality of life in menopausal women. The analysis of 2 clinical cases of the appointment of menopausal hormone therapy in patients with comorbid diseases was carried out.
Conclusions. The importance of awareness of outpatient doctors in the diagnosis and management tactics of patients with comorbid diseases in menopause is emphasized.

Key words: menopause, comorbid diseases, menopausal hormone therapy.

About the Author

Tatyana Yu. Pestrikova 1 , Elena A. Yurasova 1 , Olga G. Sherbakova 2 , Marina А. Shveeva 1

1 Far Eastern State Medical University, Khabarovsk, Russia

2 Far East Center for Innovative Diagnostics and Endoscopic Surgery (Max-Clinic), Khabarovsk, Russia

References

1. Rukovodstvo po reproduktivnoi meditsine. Ed. B. Karra, R. Blekuella i R. Aziza. Per. s angl. Moscow: Praktika, 2015 (in Russian).
2. Eurostat. Population on 1 January by age and sex [demo_pjan]. http://epp.eurostat.ec.europa.eu/portal/page/portal/population/data/database
3. Chislennost' naseleniia Rossiiskoi Federatsii po polu i vozrastu na 
1 ianvaria 2020 goda. Statisticheskii biulleten'. https://rosstat. gov.ru/compendium/document/13284 (in Russian).
4. Il'ina L.M., Iureneva S.V., Dubrovina A.V., Ebzieva Z.Kh. Vliianie menopauzy na rabotaiushchikh zhenshchin: faktor, kotoromu ne pridaetsia dolzhnogo znacheniia. Problemy reproduktsii. 2016; 1: 87–94 (in Russian).
5. Meditsina klimakteriia. Ed. V.P. Smetnik. Moscow, 2006 (in Russian).
6. Matstsa D. Spravochnik po ginekologii. Per. s angl. Ed. G.T. Sukhikh, I.A. Apolikhinoi. Moscow: Prakticheskaia meditsina, 2017 (in Russian).
7. Baber R J, Panay N, Fenton A. IMS Writing Group 2016 IMS Recommendations on women's midlife health and menopause hormone therapy. Climacteric 2016; 19: 109–50. 
8. Raz R. Hormone replacement therapy or prophylaxis in postmenopausal women with recurrent urinary tract infection. J Infect Dis 2001; 183 (Suppl. 1): S74–6.
9. Foxman B, Somsel P, Tallman P et al. Urinary tract infection among women aged 40–65: behavioral and sexual risk factors. J Clin Epidemiol 2001; 54: 710–8.
10. Marielle AJ, Beerepoot, Gerben ter Riet. Lactobacilli vs Antibiotics to Prevent Urinary Tract Infections. Arch Intern Med 2012; 172 (9): 704–12.
11. Beerepoot M, Geerlings S. Non-Antibiotic Prophylaxis for Urinary Tract Infections. Pathogens 2016, 5 (2): 36. DOI: 10.3390/ pathogens5020036
12. Apolikhina I.A., Gorbunova E.A. Kliniko-morfologicheskie aspekty vul'vovaginal'noi atrofii. Meditsinskii sovet. 2014; 9: 110–7 (in Russian).
13. Griffiths A, MacLennan SJ, Hassard J. Menopause and work: an electronic survey of employees attitudes in the UK. Maturitas 2013; 76 (2): 155–9. DOI: 0.1016/j.maturitas.2013.07.005
14. De Villiers TJ, Pines A, Panay N et al; on behalf of the International Menopause Society. Updated 2013 International Menopause Society recommendations on menopausal hormone therapy and preventive strategies for midlife health. Climacteric 2013; 16: 316–37.
15. Lobo RA, Davis SR, De Villiers TJ et al. Prevention of diseases after menopause. Climacteric 2014; 17: 1–17.
16. Preston RA, Norris PM, Alonso AB et al. Randomized, placebo-controlled, trial of the effects of drospirenone-estradiol on blood pressure and potassium balance in hypertensive postmenopausal women receiving hydrochlorothiazide. Menopause 2007; 14: 408–14.
17. Pestrikova T.Iu., Iurasova E.A., Iachinskaia T.V., Kovaleva T.D. Menopauzal'naia gormonal'naia terapiia ili negormonal'noe lechenie: ratsional'nyi vybor. Ginekologiia. 2015; 17 (3): 34–9 (in Russian).
18. Ference BA, Bhatt DL, Catapano AL et al. Association of Genetic Variants Related to Combined Exposure to Lower Low-Density Lipoproteins and Lower Systolic Blood Pressure With Lifetime Risk of Cardiovascular Disease. JAMA 2019; 322 (14): 1381–91. DOI: 10.1001/jama.2019.14120
19. Schierbeck LL, Rejnmark L, Tofteng CL et al. Effect of hormone replacement therapy on cardiovascular events in recently postmenopausal women: randomized trial. BMJ 2012; 345: e6409.
20. Lobo RA, Davis SR, De Villiers TJ et al. Prevention of diseases after menopause. Climacteric 2014; 17: 1–17.
21. Boardman HM, Hartley L, Eisinga A et al. Hormone therapy for preventing cardiovascular disease in post-menopausal women. Cochrane Database Syst Rev 2015; 3: CD002229
22. Mikkola TS, Tuomikoski P, Lyytinen H et al. Estradiol-based postmenopausal hormone therapy and risk of cardiovascular and all-cause mortality. Menopause 2015; 22: 976–83.
23. Hodis HN, Mack WJ, Henderson VW et al; ELITE Research Group. Vascular effects of early versus late postmenopausal treatment with estradiol. N Engl J Med 2016; 374: 1221–31.
24. Manson JE, Aragaki AK, Rossouw JE et al. Menopausal hormone therapy and long-term all-cause and cause-specific mortality: the Women's Health Initiative randomized trials. JAMA 2017; 318: 
927–38.
25. Baber RJ, Panay N, Fenton A, and the IMS Writing Group. 2016 IMS Recommendations on women’s midlife health and menopause hormone therapy. Climacteric 2016; 19 (2): 109–50.
26. Pestrikova T.Iu., Iurasova E.A., Iurasov I.V. et al. Vozmozhnost' profilaktiki tromboembolicheskikh oslozhnenii u zhenshchin na fone priema zamestitel'noi gormonal'noi/menopauzal'noi terapii (obzor literatury). Trudnyi patsient. 2018; 16 (1–2): 5–8 (in Russian).
27. Bergendal A, Persson I, Odeberg J et al. Association of venous thromboembolism with hormonal contraception and thrombophilic genotypes. Obstet Gynecol 2014; 124 (3): 600–9.
28. Mantha S, Karp R, Raghavan V et al. Assessing the risk of venous thromboembolic events in women taking progestin-only contraception: a meta-analysis. BMJ 2012; 345: e4944.
29. Menopauzal'naia gormonoterapiia i sokhranenie zdorov'ia zhenshchin zrelogo vozrasta. Klinicheskie rekomendatsii: protokoly. Moscow, 2015 (in Russian).
30. Herber-Gast G, Brown WJ, Mishra GD. Hot flushes and night sweats are associated with coronary heart disease risk in midlife: a longitudinal study. BJOG 2015; 122: 1560–7.
31. Thurston RC, El Khoudary SR, Sutton-Tyrrell K et al. Vasomotor symptoms and insulin resistance in the Study of women's health across the nation. J Clin Endocrinol Metab 2012; 97: 3487–94.
32. Duffy OK, Iversen L, Aucott L, Hannaford PC. Factors associated with resilience or vulnerability to hot flushes and night sweats during the menopausal transition. Menopause 2013; 20: 383–92.

For citation:Pestrikova T.Yu., Yurasova E.A., Sherbakova O.G., Shveeva M.A. Postmenopausal women – comorbid patients. Clinical review for general practice. 2020; 3: 30–38. DOI: 10.47407/kr2020.1.3.00021


All accepted articles publish licensed under a Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.

  • About
  • Editorial board
  • Ethics
  • For authors
  • Author fees
  • Peer review
  • Contacts

oa
crossref
анри


  Indexing

doaj
elibrary

Address of the Editorial Office:

127055, Moscow, s/m 37

Correspondence address:

115054, Moscow, Zhukov passage, 19, fl. 2, room XI


Managing Editor:

+7 (495) 926-29-83

id@con-med.ru